Source:http://linkedlifedata.com/resource/pubmed/id/19797168
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2009-11-2
|
pubmed:abstractText |
In the setting of renal ischemia-reperfusion injury (IRI), the effect and mechanism of action of glucocorticoids are not well understood. In rat renal IRI, a single dose of dexamethasone administered before ischemia, or at the onset of reperfusion, ameliorated biochemical and histologic acute kidney injury after 24 h. Dexamethasone upregulated Bcl-xL, downregulated ischemia-induced Bax, inhibited caspase-9 and caspase-3 activation, and reduced apoptosis and necrosis of proximal tubular cells. In addition, dexamethasone decreased the number of infiltrating neutrophils and ICAM-1. We observed the protective effect of dexamethasone in neutrophil-depleted mice, suggesting a neutrophil-independent mechanism. In vitro, dexamethasone protected human kidney proximal tubular (HK-2) cells during serum starvation and IRI-induced apoptosis, but inhibition of MEK 1/2 abolished its anti-apoptotic effects in these conditions. Dexamethasone stimulated rapid and transient phosphorylation of ERK 1/2, which required the presence of the glucocorticoid receptor and was independent of transcriptional activity. In summary, in the setting of renal ischemia-reperfusion injury, dexamethasone directly protects against kidney injury by a receptor-dependent, nongenomic mechanism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1533-3450
|
pubmed:author |
pubmed-author:AllenDavid ADA,
pubmed-author:CuzzocreaSalvatoreS,
pubmed-author:HarwoodStevenS,
pubmed-author:KieswichJulius EJE,
pubmed-author:KumarSanjeevS,
pubmed-author:MazzonEmanuelaE,
pubmed-author:PatelNimesh S ANS,
pubmed-author:RafteryMartin JMJ,
pubmed-author:ThiemermannChristophC,
pubmed-author:YaqoobMuhammad MMM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2412-25
|
pubmed:dateRevised |
2010-11-2
|
pubmed:meshHeading |
pubmed-meshheading:19797168-Animals,
pubmed-meshheading:19797168-Apoptosis,
pubmed-meshheading:19797168-Dexamethasone,
pubmed-meshheading:19797168-Glucocorticoids,
pubmed-meshheading:19797168-Kidney,
pubmed-meshheading:19797168-Male,
pubmed-meshheading:19797168-Mice,
pubmed-meshheading:19797168-Mice, Inbred C57BL,
pubmed-meshheading:19797168-Neutrophils,
pubmed-meshheading:19797168-Rats,
pubmed-meshheading:19797168-Rats, Wistar,
pubmed-meshheading:19797168-Reperfusion Injury
|
pubmed:year |
2009
|
pubmed:articleTitle |
Dexamethasone ameliorates renal ischemia-reperfusion injury.
|
pubmed:affiliation |
Centre for Translational Medicine and Therapeutics, William Harvey Research Institute, St. Bartholomew's, University of London, London EC1M 6BQ, United Kingdom. drksanjeev@yahoo.com
|
pubmed:publicationType |
Journal Article
|